Changes

174 bytes added ,  16:27, 25 July 2018
Line 27: Line 27:  
inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11
 
inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11
   −
Approximately 5-8% of AML cases have inv(16)(p13.1q22) or t(16;16)(p13.1;q22) [1].
+
Approximately 5-8% of AML cases have inv(16)(p13.1q22) or t(16;16)(p13.1;q22) [1].  The translocation inv(16)(p13.1q22) or t(16;16)(p13.1;q22) leading to a CBFB-MYH11 fusion gene may be an early event in the development of Acute Myeloid Leukemia (AML) [2].
    
==Gene Overview==
 
==Gene Overview==
436

edits